Cooley advised HanAll on the transaction HanAll BioPharma and Harbour BioMed signed a collaboration and license agreement to develop, manufacture and commercialize HanAll’s two novel biologics…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
